Integrated BioPharma, Inc. (INBP) has a market capitalization of $8.7M and trades at $0.28. The 52-week range is 0.25-0.42.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 10.5, Earnings Per Share (EPS) of $0.03, annual revenue of $54.35M.
The stock has a beta of 0.55, operates in the Consumer Defensive sector.
